Segment Information (Tables)

9 Months Ended

Sep. 30, 2026

Segment Information [Abstract]

Schedule of Performance Measured Used by CODM

The following performance measures were used by the CODM:

		Quantum Drones								Genetic Diagnostic								Corporate								Total
		Three months ended								Three months ended								Three months ended								Three months ended
		September 30,								September 30,								September 30,								September 30,
		2026				2025				2026				2025				2026				2025				2026				2025
Revenue		$	966,833			$	-			$	-			$	-			$	-			$	-			$	966,833			$	-
Cost of revenue			873,243				-				-				-				-				-				873,243				-
Gross profit			93,590				-				-				-				-				-				93,590				-

Operating expenses:
Sales and marketing			287,422				-				-				-				483,728				434,827				771,150				434,827
Research and development			669,976				-				12,000				20,000				573,053				19,318				1,255,029				39,318
General and administrative			879,228				-				9,263				15,279				2,040,931				677,311				2,929,422				692,590
Total operating expenses			1,836,626				-				21,263				35,279				3,097,712				1,131,456				4,955,601				1,166,735

Other income (expense)			16,701				-				-				-				(74,859	)			(41,299	)			(58,158	)			(41,299	)
Loss from discontinued operations			-				-				-				-				(461,272	)			(1,711,312	)			(461,272	)			(1,711,312	)
Net loss		$	(1,726,335	)		$	-			$	(21,263	)		$	(35,279	)		$	(3,633,843	)		$	(2,884,067	)		$	(5,381,441	)		$	(2,919,346	)

		Quantum Drones								Genetic Diagnostic								Corporate								Total
		Nine months ended								Nine months ended								Nine months ended								Nine months ended
		September 30,								September 30,								September 30,								September 30,
		2026				2025				2026				2025				2026				2025				2026				2025
Revenue		$	966,833			$	-			$	-			$	-			$	-			$	-			$	966,833			$	-
Cost of revenue			873,243				-				-				-				-				-				873,243				-
Gross profit			93,590				-				-				-				-				-				93,590				-

Operating expenses:
Sales and marketing			287,422				-				-				-				2,224,101				2,453,249				2,511,523				2,453,249
Research and development (including in-process research and development)			5,035,208				-				42,000				76,328				757,142				153,016				5,834,350				229,344
General and administrative			1,010,683				-				48,942				57,382				8,101,207				2,802,360				9,160,832				2,859,742
Total operating expenses			6,333,313				-				90,942				133,710				11,082,450				5,408,625				17,506,705				5,542,335

Other income (expense)			16,701				-				-				-				(81,670	)			(115,141	)			(64,969	)			(115,141	)
Loss from discontinued operations			-				-				-				-				(4,001,819	)			(5,744,594	)			(4,001,819	)			(5,744,594	)
Net loss		$	(6,223,022	)		$	-			$	(90,942	)		$	(133,710	)		$	(15,165,939	)		$	(11,268,360	)		$	(21,479,903	)		$	(11,402,070	)

Schedule of Balance Sheet

		Quantum Drones								Genetic Diagnostic								Corporate								Total
		September 30,				December 31,				September 30,				December 31,				September 30,				December 31,				September 30,				December 31,
Balance Sheet		2026				2025				2026				2025				2026				2025				2026				2025
Total assets		$	10,940,177			$	-			$	2,964,411			$	4,625,794			$	4,860,697			$	701,602			$	18,765,285			$	5,327,396